StockData
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. (ETON) stock

ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30524% above fair value
$61.99−1.66 (-2.61%)

Close on Nov 18, 2026Market cap $1.77BP/E 158.9Yield –

Eton Pharmaceuticals operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Eton Pharmaceuticals's operating income for the twelve months ending Jun 30, 2026 was $16.31M. For fiscal 2025 it was -$844.00K. The highest annual figure on record is -$844.00K in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$844.00K–
FY2024Dec 31, 2024-$2.60M–
FY2023Dec 31, 2023-$1.19M–
FY2022Dec 31, 2022-$8.26M–
FY2021Dec 31, 2021-$1.50M–
FY2020Dec 31, 2020-$27.11M–
FY2019Dec 31, 2019-$18.60M–
FY2018Dec 31, 2018-$10.32M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$12.79M–
Q1 FY2026Mar 31, 2026$2.41M–
Q4 FY2025Dec 31, 2025$2.46M+291.7%
Q3 FY2025Sep 30, 2025-$1.36M-367.8%
Q2 FY2025Jun 30, 2025-$1.48M–
Q1 FY2025Mar 31, 2025-$470.00K–
Q4 FY2024Dec 31, 2024$629.00K–
Q3 FY2024Sep 30, 2024$509.00K–
Q2 FY2024Jun 30, 2024-$2.94M-175.6%
Q1 FY2024Mar 31, 2024-$800.00K–
Q4 FY2023Dec 31, 2023-$1.99M-287.7%
Q3 FY2023Sep 30, 2023-$548.00K–
Q2 FY2023Jun 30, 2023$3.88M–
Q1 FY2023Mar 31, 2023-$2.53M–
Q4 FY2022Dec 31, 2022$1.06M-19.2%
Q3 FY2022Sep 30, 2022-$2.90M–
Q2 FY2022Jun 30, 2022-$1.34M–
Q1 FY2022Mar 31, 2022-$5.09M-194.9%
Q4 FY2021Dec 31, 2021$1.31M–
Q3 FY2021Sep 30, 2021-$5.85M–
Q2 FY2021Jun 30, 2021-$2.33M–
Q1 FY2021Mar 31, 2021$5.36M–
Q4 FY2020Dec 31, 2020-$7.42M–
Q3 FY2020Sep 30, 2020-$6.27M–
Q2 FY2020Jun 30, 2020-$4.54M–
Q1 FY2020Mar 31, 2020-$8.88M–
Q4 FY2019Dec 31, 2019-$2.66M–
Q3 FY2019Sep 30, 2019-$5.04M–
Q2 FY2019Jun 30, 2019-$3.35M–
Q1 FY2019Mar 31, 2019-$7.55M–
Q4 FY2018Dec 31, 2018-$2.29M–
Q3 FY2018Sep 30, 2018-$2.37M–
Q2 FY2018Jun 30, 2018-$2.70M–
Q1 FY2018Mar 31, 2018-$2.96M–
Q3 FY2017Sep 30, 2017-$2.77M–

More Eton Pharmaceuticals figures

See a number that looks wrong?